The global cell therapy manufacturing market, valued at USD 5.68 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 15.6% from 2025 to 2034. This growth trajectory is propelled by escalating demand for personalized medicine, advancements in cell-based therapies, and increasing investments in research and development. North America and Asia Pacific are emerging as...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)